Skip to content
2000
Volume 3, Issue 1
  • ISSN: 2211-5420
  • E-ISSN: 2211-5439

Abstract

In clinical islet transplantation, islet purification reduces the amount of tissues to be transplanted by removing the acinar tissue, therefore minimizing the risks associated with intraportal infusion. On the other hand, the purification procedure may result in decreased numbers of islets recovered from digested tissue and may be traumatic for the islets. Ficoll- based density gradients are widely used in islet purification in clinical trials. Recently, purification with iodixanol was reported in an islet transplantation series with successful clinical outcomes. This review describes current advances in islet purification for clinical islet transplantation.

Loading

Article metrics loading...

/content/journals/cte/10.2174/2211542002666131230234825
2014-03-01
2025-09-04
Loading full text...

Full text loading...

/content/journals/cte/10.2174/2211542002666131230234825
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test